1. Home
  2. LFVN

as of 02-18-2026 11:21am EST

$4.92
$0.03
-0.51%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Founded: N/A Country:
N/A
Employees: N/A City: LEHI
Market Cap: 65.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 332.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
3.64%
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $3.90 - $19.28 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): -13.35% Revenue Growth (next year): 3.60%
P/E Ratio: 8.21 Index: N/A
Free Cash Flow: N/A FCF Growth: -86.84%

AI-Powered LFVN Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 17 hours ago

AI Recommendation

hold
Model Accuracy: 71.52%
71.52%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Lifevantage Corporation (Delaware) (LFVN)

Buy
LFVN Feb 9, 2026

Avg Cost/Share

$5.22

Shares

3,955

Total Value

$20,651.43

Owned After

135,508

SEC Form 4

Buy
LFVN Dec 15, 2025

Avg Cost/Share

$6.54

Shares

805

Total Value

$5,264.62

Owned After

135,508

SEC Form 4

Latest Lifevantage Corporation (Delaware) News

LFVN Breaking Stock News: Dive into LFVN Ticker-Specific Updates for Smart Investing

All LFVN News

Share on Social Networks: